This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AstraZenecas EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotecs allogeneic cell therapies are made by the in vivo reprogramming of a patients immune cells. The post AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition appeared first on MedCity News.
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurers contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace and U.S. Healthcare appeared first on MedCity News.
I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurers contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace and U.S. Healthcare appeared first on MedCity News.
Do you remember choosing between two types of COVID tests? PCR tests were highly accurate but took several days to get results. Meanwhile, antigen-based rapid tests offered results within minutes, but were far less accurate. In this week's episode, Stewart Gandolf speaks with Martin Price , CEO of HealthTrackRx , to explore how an innovative business model, leading-edge sales strategies, and game-changing partnerships has enabled HealthTrackRx to offer and scale next-morning PCR results nationwi
Life is unpredictable. Its full of challenges that can hit when we least expect them. For me, one of those challenges came at the peak of my athletic career. At 19 years old, I was living my dream as a star wide receiver for Florida State University and a black-belt kickboxer. My last fight had even been televised on ESPN. But in a single, fateful moment, everything changed.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Womens Health? appeared first on MedCity News.
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
Explore the concept of "uncertainty fatigue" and its profound impact on employees dealing with rapid workplace transformations, global events, and economic volatility. Understand the symptoms and consequences of this growing challenge and discover six practical strategies that leaders can implement to foster resilience, reduce stress, and enhance overall well-being in the workplace.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Table of Contents Understanding Paid Social Media Campaigns in Pharma Marketing Key Benefits of Paid Social Media Advertising for Pharma Brands Best Practices for Optimizing Paid Social Media Campaigns Measuring Success: How to Track ROI and Engagement Understanding Paid Social Media Campaigns in Pharma Marketing Pharmaceutical marketing has evolved significantly with the rise of paid social media campaigns , enabling brands to reach healthcare professionals (HCPs), patients, and caregivers in w
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isnt Intelligence in Healthcare appeared first on MedCity News.
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Real-world intelligence is evident in the discussions taking place on social media. Social medias position in pharmaceutical research is further cemented by peoples growing usage of it.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.
Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.
Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on Future Foundational Therapy for Obesity appeared first on MedCity News.
Cedar Knolls, NJ March 12th, 2025 Nuvera, part of Inizio Engage, has launched an expanded set of data led, insights-driven client solutions and strengthened its dynamic leadership team under the guidance of Derek Cothran, all showcased in its newly launched website. Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics.
Table of Contents Understanding the Importance of HCP Engagement in Pharma Marketing Key Marketing Strategies for Pharma Brands to Reach HCPs Optimizing Digital and Paid Media Strategies for Pharma Marketing Measuring Success: Tracking HCP Engagement and ROI Understanding the Importance of HCP Engagement in Pharma Marketing Engaging healthcare professionals (HCPs) effectively is a top priority for pharmaceutical brands.
Several years ago, Highmark began questioning its exclusive relationships with specialty pharmacies and started working with Free Market Health, which matches patients to the pharmacy that best fits their needs. The post Why This Health Plan Moved Away from Exclusive Relationships with Specialty Pharmacies appeared first on MedCity News.
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
In our latest POV by Roberto Ascione, President of EVERSANA INTOUCHs Health Innovation, and Ferdinando Scala, Director of Strategic Planning, the evolving landscape of digital health and its implications for the life sciences industry are explored with an emphasis on the importance of understanding digital determinants of health, which include factors such as internet access, digital literacy, and the availability of digital devices.
The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
274 
Let's personalize your content